nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP2D6—Parkinson's disease	0.889	1	CbGaD
Cilostazol—Aripiprazole—HTR7—Parkinson's disease	0.00273	0.179	CrCbGaD
Cilostazol—Aripiprazole—DRD3—Parkinson's disease	0.00257	0.169	CrCbGaD
Cilostazol—Aripiprazole—DRD1—Parkinson's disease	0.00252	0.166	CrCbGaD
Cilostazol—Aripiprazole—HTR1A—Parkinson's disease	0.0021	0.138	CrCbGaD
Cilostazol—Aripiprazole—DRD2—Parkinson's disease	0.00178	0.117	CrCbGaD
Cilostazol—Aripiprazole—HTR2A—Parkinson's disease	0.00137	0.0902	CrCbGaD
Cilostazol—Aripiprazole—CYP2D6—Parkinson's disease	0.00126	0.0825	CrCbGaD
Cilostazol—Aripiprazole—ABCB1—Parkinson's disease	0.000898	0.0589	CrCbGaD
Cilostazol—CYP3A7—Metabolism—OMD—Parkinson's disease	0.000124	0.00129	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PDYN—Parkinson's disease	0.000123	0.00127	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000122	0.00127	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000122	0.00126	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—HTR7—Parkinson's disease	0.00012	0.00125	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—DRD2—Parkinson's disease	0.00012	0.00125	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NDUFB11—Parkinson's disease	0.000118	0.00122	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.000117	0.00121	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000115	0.0012	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—GFAP—Parkinson's disease	0.000115	0.0012	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—GRM5—Parkinson's disease	0.000114	0.00118	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.000114	0.00118	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000113	0.00118	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000113	0.00117	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GCH1—Parkinson's disease	0.000112	0.00117	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000112	0.00117	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000112	0.00116	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000107	0.00111	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000106	0.0011	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000106	0.0011	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000105	0.00109	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000104	0.00108	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000104	0.00108	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000104	0.00108	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000103	0.00107	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000103	0.00107	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000103	0.00107	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—FBP1—Parkinson's disease	0.0001	0.00104	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—DBH—Parkinson's disease	0.0001	0.00104	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GBA—Parkinson's disease	0.0001	0.00104	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FGF20—Parkinson's disease	9.99e-05	0.00104	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	9.79e-05	0.00102	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ADORA2A—Parkinson's disease	9.69e-05	0.00101	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—EDN1—Parkinson's disease	9.64e-05	0.001	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	9.58e-05	0.000994	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ND3—Parkinson's disease	9.55e-05	0.000991	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MCCC1—Parkinson's disease	9.55e-05	0.000991	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	9.45e-05	0.00098	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—HTR2A—Parkinson's disease	9.28e-05	0.000963	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	9.04e-05	0.000938	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—OMD—Parkinson's disease	8.98e-05	0.000932	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TALDO1—Parkinson's disease	8.98e-05	0.000932	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—INSR—Parkinson's disease	8.94e-05	0.000928	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.91e-05	0.000925	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—COMT—Parkinson's disease	8.87e-05	0.000921	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	8.87e-05	0.000921	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	8.87e-05	0.000921	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	8.83e-05	0.000916	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	8.81e-05	0.000914	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	8.75e-05	0.000908	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	8.71e-05	0.000904	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	8.52e-05	0.000883	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FGB—Parkinson's disease	8.45e-05	0.000877	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—HTR2A—Parkinson's disease	8.43e-05	0.000875	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HTR1A—Parkinson's disease	8.41e-05	0.000872	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TAC1—Parkinson's disease	8.28e-05	0.000859	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	8.27e-05	0.000858	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.15e-05	0.000846	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GCH1—Parkinson's disease	8.12e-05	0.000843	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—DRD1—Parkinson's disease	8.12e-05	0.000842	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	8.12e-05	0.000842	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	8.01e-05	0.000831	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—DRD3—Parkinson's disease	7.86e-05	0.000816	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	7.84e-05	0.000814	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ND3—Parkinson's disease	7.39e-05	0.000766	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MCCC1—Parkinson's disease	7.39e-05	0.000766	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—DDC—Parkinson's disease	7.35e-05	0.000763	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ADRBK1—Parkinson's disease	7.34e-05	0.000762	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—DBH—Parkinson's disease	7.24e-05	0.000751	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—FBP1—Parkinson's disease	7.24e-05	0.000751	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GBA—Parkinson's disease	7.24e-05	0.000751	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HTR7—Parkinson's disease	7.11e-05	0.000738	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—DRD2—Parkinson's disease	7.11e-05	0.000738	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—OMD—Parkinson's disease	6.94e-05	0.000721	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TALDO1—Parkinson's disease	6.94e-05	0.000721	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTA4—Parkinson's disease	6.94e-05	0.00072	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—COMT—Parkinson's disease	6.85e-05	0.000711	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	6.82e-05	0.000707	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	6.8e-05	0.000706	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	6.79e-05	0.000705	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ND3—Parkinson's disease	6.79e-05	0.000705	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	6.75e-05	0.000701	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	6.72e-05	0.000698	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	6.58e-05	0.000683	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	6.39e-05	0.000663	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—OMD—Parkinson's disease	6.39e-05	0.000663	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GCH1—Parkinson's disease	6.28e-05	0.000652	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	6.26e-05	0.00065	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	6.25e-05	0.000649	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—MAOB—Parkinson's disease	6.19e-05	0.000642	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	6.18e-05	0.000641	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	6.11e-05	0.000634	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	6.05e-05	0.000628	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IGF2—Parkinson's disease	5.96e-05	0.000618	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GCH1—Parkinson's disease	5.78e-05	0.000599	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IGF1R—Parkinson's disease	5.76e-05	0.000598	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MCCC1—Parkinson's disease	5.75e-05	0.000597	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ND3—Parkinson's disease	5.75e-05	0.000597	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EDN1—Parkinson's disease	5.69e-05	0.000591	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.66e-05	0.000588	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—DBH—Parkinson's disease	5.6e-05	0.000581	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—FBP1—Parkinson's disease	5.6e-05	0.000581	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GBA—Parkinson's disease	5.6e-05	0.000581	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TALDO1—Parkinson's disease	5.41e-05	0.000561	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—OMD—Parkinson's disease	5.41e-05	0.000561	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—DDC—Parkinson's disease	5.31e-05	0.000551	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NGF—Parkinson's disease	5.23e-05	0.000543	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—DBH—Parkinson's disease	5.15e-05	0.000534	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.15e-05	0.000534	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GBA—Parkinson's disease	5.15e-05	0.000534	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	5.13e-05	0.000532	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTA4—Parkinson's disease	5.02e-05	0.000521	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HTR2A—Parkinson's disease	4.98e-05	0.000517	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GCH1—Parkinson's disease	4.89e-05	0.000508	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—APOE—Parkinson's disease	4.63e-05	0.00048	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	4.6e-05	0.000477	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	4.52e-05	0.000469	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CTGF—Parkinson's disease	4.51e-05	0.000468	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MAOB—Parkinson's disease	4.47e-05	0.000464	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.44e-05	0.000461	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ND3—Parkinson's disease	4.44e-05	0.000461	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.41e-05	0.000458	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GBA—Parkinson's disease	4.36e-05	0.000453	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—DBH—Parkinson's disease	4.36e-05	0.000453	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—FBP1—Parkinson's disease	4.36e-05	0.000453	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	4.21e-05	0.000436	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—OMD—Parkinson's disease	4.18e-05	0.000433	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.18e-05	0.000433	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NQO1—Parkinson's disease	4.16e-05	0.000432	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—DDC—Parkinson's disease	4.11e-05	0.000426	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—TH—Parkinson's disease	4.1e-05	0.000425	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.96e-05	0.000411	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—INS—Parkinson's disease	3.96e-05	0.00041	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYCS—Parkinson's disease	3.94e-05	0.000408	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTA4—Parkinson's disease	3.88e-05	0.000403	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.83e-05	0.000397	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—DDC—Parkinson's disease	3.78e-05	0.000392	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.78e-05	0.000392	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.57e-05	0.00037	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	3.49e-05	0.000362	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—COMT—Parkinson's disease	3.49e-05	0.000362	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTP1—Parkinson's disease	3.47e-05	0.00036	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—MAOA—Parkinson's disease	3.46e-05	0.000359	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MAOB—Parkinson's disease	3.46e-05	0.000359	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—HMOX1—Parkinson's disease	3.42e-05	0.000355	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—DBH—Parkinson's disease	3.37e-05	0.000349	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.37e-05	0.000349	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GBA—Parkinson's disease	3.37e-05	0.000349	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	3.32e-05	0.000345	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.29e-05	0.000341	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ABCB1—Parkinson's disease	3.28e-05	0.000341	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CTGF—Parkinson's disease	3.26e-05	0.000339	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.21e-05	0.000333	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—DDC—Parkinson's disease	3.2e-05	0.000332	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTM1—Parkinson's disease	3.19e-05	0.000331	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.18e-05	0.00033	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GPX1—Parkinson's disease	3.05e-05	0.000317	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	3.04e-05	0.000315	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTA4—Parkinson's disease	3.02e-05	0.000314	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NQO1—Parkinson's disease	3.01e-05	0.000312	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.98e-05	0.00031	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TH—Parkinson's disease	2.96e-05	0.000307	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CASP3—Parkinson's disease	2.94e-05	0.000306	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL6—Parkinson's disease	2.93e-05	0.000304	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYCS—Parkinson's disease	2.84e-05	0.000295	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—MTHFR—Parkinson's disease	2.82e-05	0.000292	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.72e-05	0.000282	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MAPK8—Parkinson's disease	2.71e-05	0.000281	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.69e-05	0.00028	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—APOE—Parkinson's disease	2.62e-05	0.000272	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	2.57e-05	0.000267	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.56e-05	0.000266	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.52e-05	0.000262	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—COMT—Parkinson's disease	2.52e-05	0.000261	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—Parkinson's disease	2.51e-05	0.00026	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MAOA—Parkinson's disease	2.5e-05	0.00026	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—HMOX1—Parkinson's disease	2.47e-05	0.000257	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—DDC—Parkinson's disease	2.47e-05	0.000256	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ABCB1—Parkinson's disease	2.37e-05	0.000246	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.35e-05	0.000244	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.33e-05	0.000242	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.32e-05	0.000241	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.32e-05	0.000241	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTM1—Parkinson's disease	2.3e-05	0.000239	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TH—Parkinson's disease	2.29e-05	0.000238	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—INS—Parkinson's disease	2.24e-05	0.000232	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GPX1—Parkinson's disease	2.21e-05	0.000229	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.2e-05	0.000228	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.16e-05	0.000224	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.14e-05	0.000222	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TH—Parkinson's disease	2.11e-05	0.000219	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.1e-05	0.000218	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.08e-05	0.000216	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MTHFR—Parkinson's disease	2.04e-05	0.000211	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.02e-05	0.00021	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	2e-05	0.000208	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.97e-05	0.000204	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—COMT—Parkinson's disease	1.95e-05	0.000202	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.94e-05	0.000201	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.93e-05	0.000201	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.91e-05	0.000198	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—APOE—Parkinson's disease	1.9e-05	0.000197	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.84e-05	0.00019	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.83e-05	0.00019	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.81e-05	0.000188	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—COMT—Parkinson's disease	1.79e-05	0.000186	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TH—Parkinson's disease	1.78e-05	0.000185	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.78e-05	0.000185	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.78e-05	0.000185	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.78e-05	0.000185	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.76e-05	0.000182	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6—Parkinson's disease	1.73e-05	0.000179	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.71e-05	0.000178	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.71e-05	0.000177	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.69e-05	0.000175	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.64e-05	0.00017	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—INS—Parkinson's disease	1.62e-05	0.000168	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.57e-05	0.000163	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.57e-05	0.000163	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.55e-05	0.00016	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—COMT—Parkinson's disease	1.52e-05	0.000157	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.52e-05	0.000157	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.51e-05	0.000157	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.51e-05	0.000156	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.49e-05	0.000155	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—APOE—Parkinson's disease	1.47e-05	0.000152	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.45e-05	0.00015	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.43e-05	0.000148	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.41e-05	0.000147	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.4e-05	0.000145	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.39e-05	0.000144	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TH—Parkinson's disease	1.38e-05	0.000143	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.35e-05	0.00014	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.33e-05	0.000138	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.32e-05	0.000137	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—INS—Parkinson's disease	1.25e-05	0.00013	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.23e-05	0.000127	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—COMT—Parkinson's disease	1.17e-05	0.000122	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.17e-05	0.000121	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.16e-05	0.000121	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—INS—Parkinson's disease	1.15e-05	0.000119	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.15e-05	0.000119	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—APOE—Parkinson's disease	1.14e-05	0.000118	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.1e-05	0.000114	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.07e-05	0.000111	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.03e-05	0.000106	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—INS—Parkinson's disease	9.76e-06	0.000101	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTHFR—Parkinson's disease	9.47e-06	9.82e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—APOE—Parkinson's disease	8.81e-06	9.15e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—INS—Parkinson's disease	7.53e-06	7.81e-05	CbGpPWpGaD
